You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-Chemokine (C-C Motif) Ligand 13 (CCL13) Anticorps

Full name:
anti-Chemokine (C-C Motif) Ligand 13 Anticorps (CCL13)
Chez sont 105 Chemokine (C-C Motif) Ligand 13 (CCL13) Anticorps de 16 de différents fournisseurs disponibles. De plus, nous expédions Chemokine (C-C Motif) Ligand 13 Kits (40) et Chemokine (C-C Motif) Ligand 13 Protéines (35) et beaucoup plus de produits pour cette protéine. Un total de 186 Chemokine (C-C Motif) Ligand 13 produits sont actuellement listés.
CKb10, Mcp-4, Mcp4, MMCP-4, MMCP-4A, MMCP-4B, NCC-1, NCC1, SCYA13, SCYL1
afficher tous les anticorps Gène GeneID UniProt
CCL13 6357 Q99616
CCL13 17227 P21812

Afficher toutes les espèces

Afficher tous les synonymes

Réactivités les plus populaires pour anti-Chemokine (C-C Motif) Ligand 13 (CCL13) Anticorps

Sélectionnez vos espèces et l'application

anti-Human Anticorps:

anti-Mouse (Murine) Anticorps:

anti-Rat (Rattus) Anticorps:

Tous anti-Chemokine (C-C Motif) Ligand 13 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-Chemokine (C-C Motif) Ligand 13 Anticorps mieux référencés

  1. Human Polyclonal CCL13 Primary Antibody pour WB - ABIN2792189 : Kalayci, Birben, Wu, Oguma, Storm Vans Gravesande, Subramaniam, Sheldon, Silverman, Lilly: Monocyte chemoattractant protein-4 core promoter genetic variants: influence on YY-1 affinity and plasma levels. dans American journal of respiratory cell and molecular biology 2003 (PubMed)

  2. Human Monoclonal CCL13 Primary Antibody pour ELISA (Capture), FACS - ABIN4899862 : Gounni Abdelilah, Wellemans, Agouli, Guenounou, Hamid, Beck, Lamkhioued: Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines. dans Clinical immunology (Orlando, Fla.) 2006 (PubMed)

Plus d’anticorps contre Chemokine (C-C Motif) Ligand 13 partenaires d’interaction

Human Chemokine (C-C Motif) Ligand 13 (CCL13) interaction partners

  1. CCL13 expression is significantly upregulated in human masticatory mucosa during wound healing

  2. The reduction of circulating levels of MCP-4, eotaxin-3 (Montrer CCL26 Anticorps), and MIP-1beta (Montrer CCL4 Anticorps) could be one of the mechanisms by which bariatric surgery contributes to the reduction of cardiovascular risk in these patients.

  3. CCL13 levels in serum and synovial fluid may serve as a biomarker for the progression of osteoarthritis.

  4. identified 13 ADCC-activated genes. Six gene expression assays including 8 of the 13 genes (CCL3 (Montrer CCL3 Anticorps), CCL4/CCL4L1 (Montrer CCL4 Anticorps)/CCL4L2, CD160 (Montrer CD160 Anticorps), IFNG (Montrer IFNG Anticorps), NR4A3 (Montrer NR4A3 Anticorps) and XCL1 (Montrer XCL1 Anticorps)/XCL2 (Montrer XCL2 Anticorps)) were analyzed in 127 kidney biopsies

  5. CCL13 is an antimicrobial protein with bacteriocidal activity against E. coli.

  6. Data suggest that CCL13 binds to several chemokine (Montrer CCL1 Anticorps) receptors (CCR1, CCR2 (Montrer CCR2 Anticorps), and CCR3 (Montrer CCR3 Anticorps)), allowing CCL13 to elicit different effects on target cells of immune system. CCL13 is involved in pathology of chronic inflammatory/autoimmune diseases. [REVIEW]

  7. MCP-4 and hsCRP may be the markers linking chronic inflammation in obesity and periodontal disease.

  8. E(2) has adverse effects on the pathogenesis of RA as a result of unregulated cell death, increased TNF-alpha (Montrer TNF Anticorps)-induced MMP-3 (Montrer MMP3 Anticorps) production, and CCL13 overproduction, subsequently resulting in the disease progression of RA.

  9. Data show that, for the small macrophages in COPD (Montrer ARCN1 Anticorps), increased transcript and protein levels for CCL2 (Montrer CCL2 Anticorps), CCL7 (Montrer CCL7 Anticorps), CCL13 and CCL22 (Montrer CCL22 Anticorps) with a more than 100-fold increase for CCL13 mRNA.

  10. Findings suggest that the pro-atherogenic effects of CCR2 (Montrer CCR2 Anticorps) may not be restricted to interaction with MCP-1 (Montrer CCL2 Anticorps), but could also involve activation by MCP-4, being an inflammatory link between platelet and monocyte activation.

Mouse (Murine) Chemokine (C-C Motif) Ligand 13 (CCL13) interaction partners

  1. Data indicate that a second-degree burn injury can initiate an immediate novel zonal degranulation of mast cell throughout all skin layers and a disruption of the epidermal tight junctions dependent on the nonredundant presence of mMCP4 and mMCP5 (Montrer CMA1 Anticorps).

  2. these results support the conclusion that mast cells can contribute to the initial lung injury induced by bleomycin through release of the MCPT4 chymase (Montrer CMA1 Anticorps).

  3. Mast cell chymase (Montrer CMA1 Anticorps) degrades the alarmins heat shock protein 70 (Montrer HSP70 Anticorps), biglycan (Montrer BGN Anticorps), HMGB1 (Montrer HMGB1 Anticorps), and interleukin-33 (IL-33 (Montrer IL33 Anticorps)) and limits danger-induced inflammation.

  4. Data from Mcp-4 (mast cell protease 4) knockout mice suggest Mcp-4 plays a pivotal role in the dynamic (in vivo and in vitro) conversion of systemic Big-endothelin-1 (Montrer EDN1 Anticorps) to endothelin-1 (Montrer EDN1 Anticorps) (1-31).

  5. MCs (Montrer SMCP Anticorps) exert protective functions after trauma, at least in part via mMCP-4, by suppressing exacerbated inflammation via their proteases.

  6. The effects of interactions between mMCP-4 and TNF (Montrer TNF Anticorps) in vivo by analyzing the features of a classic model of polymicrobial sepsis, were assessed.

  7. mMCP-4 plays two different roles in the pathogenesis of experimental BP, by both activating MMP-9 (Montrer MMP9 Anticorps) and by cleaving BP180 (Montrer COL17A1 Anticorps), leading to injury of the hemidesmosomes and extracellular matrix of the basement membrane zone.

  8. mMCP-4-deficient mice but not to mMCP-5 (Montrer CMA1 Anticorps)-deficient mice revealing nonredundant actions for these two MC proteases in a model of innate inflammatory injury with remodeling.

  9. MCP-4 contributes locally to the aggravation of glomerulonephritis by mediating a variety of proinflammatory effects.

  10. mice deficient in mast cells (Kit(W-sh/W-sh) [Wsh]) or mast cell chymase (Mcpt4(-/-)) have significantly decreased basal small intestinal permeability compared with wild-type (WT) mice

Chemokine (C-C Motif) Ligand 13 (CCL13) profil antigène

Antigen Summary

This gene is one of several Cys-Cys (CC) cytokine genes clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. This chemokine plays a role in accumulation of leukocytes during inflammation. It may also be involved in the recruitment of monocytes into the arterial wall during artherosclerosis.

Alternative names and synonyms associated with Chemokine (C-C Motif) Ligand 13 (CCL13)

  • chemokine (C-C motif) ligand 13 (CCL13) anticorps
  • mast cell protease 4 (Mcpt4) anticorps
  • CKb10 anticorps
  • Mcp-4 anticorps
  • Mcp4 anticorps
  • MMCP-4 anticorps
  • MMCP-4A anticorps
  • MMCP-4B anticorps
  • NCC-1 anticorps
  • NCC1 anticorps
  • SCYA13 anticorps
  • SCYL1 anticorps

Protein level used designations for CCL13

C-C motif chemokine 13 , CK-beta-10 , monocyte chemoattractant protein 4 , monocyte chemotactic protein 4 , new CC chemokine 1 , small inducible cytokine subfamily A (Cys-Cys), member 13 , small-inducible cytokine A13 , monocyte chemotactic protein-4 , MSMCP , myonase , serosal mast cell protease

6357 Homo sapiens
445451 Canis lupus familiaris
17227 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-Chemokine (C-C Motif) Ligand 13 (CCL13) Anticorps
Avez-vous cherché autre chose?